Heidi van der Ende-Metselaar

Heidi van der Ende-Metselaar is a researcher at the University Medical Center Groningen (UMCG), part of the University of Groningen in the Netherlands. She holds the Dutch engineering title "ing." and is actively engaged in virology research with recent publications spanning from 2021 to 2024.

Her research focuses on viral pathogenesis and antiviral therapeutics, with particular expertise in flaviviruses such as dengue virus and alphaviruses like chikungunya virus. Her work spans multiple approaches including:

• Investigating plant-derived compounds as antiviral agents
• Studying viral replication mechanisms in different cell models
• Developing novel approaches to inhibit viral infection and tissue damage
• Exploring advanced technologies like quantum sensing for virology research

Analysis of her publication record reveals a strong translational focus, with work on SARS-CoV-2 antivirals, dengue virus pathogenesis, and chikungunya virus replication. She frequently collaborates with leading virologists at UMCG including Judith Smit and Irene Rodenhuis-Zybert. Her research demonstrates particular attention to physiological relevance by testing compounds in human primary airway epithelial cells rather than just standard cell lines.

Dr. van der Ende-Metselaar's work aligns with UN Sustainable Development Goals related to good health and well-being, with her research fingerprint highlighting expertise in Dengue Virus (100%), Viral Disease (67%), Chikungunya Virus (43%), and Viral Replication (31%).

Her research has gained scientific attention with multiple publications accumulating citations, some being referenced in patents, and receiving media coverage through news outlets and social media platforms.